Carboplatin Shows Substantial Promise in Peritoneal Mesothelioma Treatment, Baron and Budd Reports

Study Indicates Carboplatin Can Deliver Superior Performance When Compared to Other Chemotherapy Drugs Los Angeles, CA (PRWEB) June 19, 2014 A study conducted by a surgical team at Creighton University Medical Center in Omaha, Nebraska published April 8, 2014, has shown what researchers believe is the correct chemotherapy drug to use in conjunction with surgery in patients suffering from peritoneal mesothelioma, reports the national law firm of Baron and Budd. As a result, survival rates may increase substantially. (http://www.ncbi.nlm.nih.gov/pubmed/24887664) A rare form of asbestos canc
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories